Clinical trial
Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia
NCT00114595 · University of Stellenbosch, Other · Completed
Key facts
| NCT number | NCT00114595 |
|---|---|
| Title | Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia |
| Official title | A Double-Blind, Randomised, Parallel-Group Comparison of Ethyl-Eicosapentaenoic Acid (Ethyl-EPA) Versus Placebo as Add-on Medication in Patients With Established Tardive Dyskinesia |
| Lead sponsor | University of Stellenbosch, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dyskinesia, Schizophrenia |
| Intervention type | Drug |
| Interventions | eicosapentaenoic acid |
| Enrollment | 84 |
| Start date | Apr 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Jun 16, 2005 |
| Last update posted | Jun 24, 2005 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: